Back Dictionary Export CSV
Filter: Clear
MERGED_REGIMEN_ID MERGED_TUMOUR_ID HEIGHT_AT_START_OF_REGIMEN WEIGHT_AT_START_OF_REGIMEN INTENT_OF_TREATMENT DATE_DECISION_TO_TREAT START_DATE_OF_REGIMEN MAPPED_REGIMEN CLINICAL_TRIAL CHEMO_RADIATION MERGED_PATIENT_ID BENCHMARK_GROUP
330009493 330003221 1.72 77 null 2017-06-06 2017-07-16 Cisplatin 100 + RT(H&N) 1 day 02 Y 330001925 CISPLATIN + RT
330009494 330003226 1.76 null Curative (C) 2013-03-30 2013-04-03 Cisplatin + Radiotherapy null Y 330001934 CISPLATIN + RT
330009495 330003228 1.08 null Curative (C) 2015-04-01 2015-05-30 NB HRNBL-1 TVD Y N 330001965 NOT MATCHED
330009496 330003229 1.64 55.8 Adjuvant (A) 2014-05-08 2014-05-15 Cisplatin + Radiotherapy N null 330001965 CISPLATIN + RT
330009497 330003231 null 59.05 Palliative (P) 2015-10-02 2016-04-04 NB HRNBL-1 ch14.18/CHO(trial) +IL-2 2 N 330001982 NOT MATCHED
330009498 330003237 null 60.2 Curative (C) 2013-10-28 2013-10-29 Cisplatin + Radiotherapy null Y 330002000 CISPLATIN + RT
330009499 330003238 null 16.8 Curative (C) 2016-06-02 2016-06-03 CNS LGG 2004 03 cons vinc + carbo 02 N 330002000 NOT MATCHED
330009500 330003239 0 19.9 Curative (C) 2015-08-17 2015-08-17 BMT Y N 330002010 NOT MATCHED
330009501 330003240 0.92 103.4 Neo-adjuvant (N) 2017-11-03 2017-11-18 NB HRNBL-1 COJEC Ind COURSE B 01 N 330002025 NOT MATCHED
330009502 330007724 1.13 67.7 Neo-adjuvant (N) null 2017-05-11 CYTARABINE + ETOPOSIDE + MITOXANTRONE Y N 330002044 NOT MATCHED
330009503 330003249 1.6 59.2 Adjuvant (A) 2015-03-23 2015-03-23 CISPLATIN + RT 02 N 330002051 CISPLATIN + RT
330009504 330007726 0 37.2 Curative (C) 2014-06-17 2014-07-08 null Y N 330002063 NOT MATCHED
330009505 330003256 1.93 60 Adjuvant (A) 2016-03-24 2016-05-01 Cisplatin + Radiotherapy 02 Y 330002068 CISPLATIN + RT
330009506 330003257 null 17 Curative (C) 2013-08-02 2013-08-04 null 01 N 330002078 NOT MATCHED
330009507 330003261 null 53.75 Not known (9) 2014-10-17 2014-10-18 CISPLATIN + RT 02 Y 330002101 CISPLATIN + RT
330009508 330003264 0 11.1 Curative (C) 2016-11-28 2016-12-04 LCHIV Cont A null null 330002128 NOT MATCHED
330009509 330003266 1.68 88.8 null 2013-06-26 2013-07-18 Cisplatin 100 + RT(H&N) 1 day null null 330002151 CISPLATIN + RT
330009510 330003268 1.6 16.4 Palliative (P) 2015-02-11 2015-02-14 NB HRNBL-1 TVD N N 330002162 NOT MATCHED
330009511 330003269 null 20.5 Curative (C) 2015-03-08 2016-02-26 EW EuroEwing 2012 Arm A VAC 01 N 330002165 NOT MATCHED
330009512 330003270 1.43 13.3 Palliative (P) 2014-03-07 2014-03-24 NB HRNBL-1 TVD 01 N 330002177 NOT MATCHED
330009513 330003272 1.65 null Curative (C) 2013-10-27 2014-01-04 CNS LGG2004 03 vinc + carbo N N 330002186 NOT MATCHED
330009514 330003273 null 10.8 Adjuvant (A) 2016-02-13 2016-02-29 NB Rel CCLG guidelines Cyclo-Topotecan N Y 330002189 NOT MATCHED
330009516 330003275 0 59 Adjuvant (A) 2016-03-23 2016-12-01 NB HRNBL-1 TVD 01 null 330002195 NOT MATCHED
330009517 330003277 0 15.7 Adjuvant (A) 2013-12-14 2014-05-24 EW EuroEwing 2012 Arm A VAC N N 330002201 NOT MATCHED
330009518 330003279 0 11.5 Curative (C) null 2016-02-10 NB HRNBL-1 COJEC Ind COURSE B null null 330002205 NOT MATCHED
330009519 330003281 1.47 101 Adjuvant (A) 2017-12-30 2018-01-08 CISPLATIN + RT null null 330002231 CISPLATIN + RT
330009520 330003284 0 14.8 Palliative (P) 2013-07-09 2013-10-15 CNS GCT II Germinoma - Ifos Etop Y null 330002251 NOT MATCHED
330009521 330003285 null 52 Curative (C) 2012-12-29 2013-06-11 NB HRNBL-1 TVD Y N 330002276 NOT MATCHED
330009522 330003285 0 88.8 Adjuvant (A) 2014-04-03 2014-04-26 CISPLATIN + RT 02 N 330002276 CISPLATIN + RT
330009523 330007746 1.78 null Neo-adjuvant (N) 2015-02-12 2015-12-15 Cisplatin 100 + RT(H&N) 1 day 02 N 330002295 CISPLATIN + RT
330009524 330003289 0 10.85 Curative (C) 2016-08-04 2016-08-04 NB HRNBL-1 COJEC Ind COURSE C null Y 330002311 NOT MATCHED
330009525 330003291 1.8 69 null 2016-06-17 2017-11-12 Cisplatin 100 + RT(H&N) 1 day N Y 330002317 CISPLATIN + RT
330009526 330003293 1.8 104 Palliative (P) 2016-05-22 2016-06-27 Cisplatin 100 + RT(H&N) 1 day N Y 330002340 CISPLATIN + RT
330009527 330003296 0 null Curative (C) 2014-03-05 2014-04-05 NB HRNBL-1 COJEC Ind COURSE C Y Y 330002377 NOT MATCHED
330009528 330011582 1.72 73.2 2 2013-08-17 2013-11-03 Cisplatin 100 + RT(H&N) 1 day N null 330002381 CISPLATIN + RT
330009529 330003297 1.83 73 Curative (C) 2016-11-28 2016-12-13 CISPLATIN + RT 02 Y 330002407 CISPLATIN + RT
330009530 330003298 1.8 129.3 Curative (C) 2014-11-29 2014-12-04 Cisplatin 100 + RT(H&N) 1 day null N 330002420 CISPLATIN + RT
330009531 330003299 null null Curative (C) 2013-12-09 2013-12-09 Cisplatin 100 + RT(H&N) 1 day null N 330002460 CISPLATIN + RT
330009532 330007757 1.63 64 Curative (C) 2015-05-17 2015-06-12 CISPLATIN + RT null Y 330002463 CISPLATIN + RT
330009533 330003304 1.73 57 Adjuvant (A) 2016-03-16 2016-03-17 CISPLATIN + RT 02 Y 330002466 CISPLATIN + RT
330009534 330003306 0.75 7 Curative (C) 2013-10-21 2013-10-21 NB HRNBL-1 Isotretinoin Y N 330002481 NOT MATCHED
330009535 330003309 1.72 72 Curative (C) 2018-08-08 2018-08-08 Cisplatin + Radiotherapy 2 Y 330002513 CISPLATIN + RT
330009536 330007760 1.72 null Curative (C) 2017-02-12 2017-02-14 CISPLATIN + RT N Y 330002520 CISPLATIN + RT
330009537 330007761 null 55.3 Curative (C) null 2016-10-03 null N null 330002528 NOT MATCHED
330009538 330007761 0 10 Palliative (P) 2015-07-10 2015-07-10 EW EuroEwing 2012 Arm A VAC N N 330002528 NOT MATCHED
330009539 330007764 1.55 null Curative (C) 2015-12-05 2015-12-05 CISPLATIN + RT 2 N 330002554 CISPLATIN + RT
330009540 330003317 0 37.4 Disease modification (D) null 2016-06-09 NB HRNBL-1 MOD N7 CAV 02 N 330002562 NOT MATCHED
330009543 330003323 null 86.5 Curative (C) 2014-06-03 2014-07-04 Cisplatin 100 + RT(H&N) 1 day 02 N 330002610 CISPLATIN + RT
330009544 330003325 0 25.3 Neo-adjuvant (N) null 2013-07-04 NB HRNBL-1 COJEC Ind COURSE B null null 330002628 NOT MATCHED
330009545 330007771 1.54 83.2 null 2016-07-19 2016-08-03 Cisplatin 100 + RT(H&N) 1 day N N 330002637 CISPLATIN + RT